Pharmacokinetics, metabolism and bioavailability of the new anti- allergic drug BM 113: Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 8, 1999, Pages 699-704

  Duchêne, Patrick ^b   Laneury, Jean Paul ^c   Tran, Gilles ^c   Ladure, Philippe ^c   Ollivier, Roland ^c   Buzas, André ^c   Merour, Jean Yves ^c   Houin, Georges ^a  

^a CHU RANGUEIL   (France)

^b ADME BIOANALYSES   (France)

^c NONE

Author keywords

1 (Benzhydryloxyethyl)piperidino 4 ethylacetate; Antiallergic drugs; BM 113, humans, metabolism, pharmacokinetics; BM 212; CAS 115313 91 2; CAS 115313 90 1

Indexed keywords

1 (BENZHYDRYLOXYETHYL)PIPERIDINO 4 ETHYLACETATE; ANTIALLERGIC AGENT; DRUG DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SEX DIFFERENCE; URINARY EXCRETION;

EID: 0032810545     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300485     Document Type: Article

References (3)

1. [1] Buzas, A., Mcrour, J. Y., Ollivier, R., EP 87401959, 18 pp, 02/09/87
2. [2] Duchêne, P., Tran, G., Ladure, P. et al., Arzneim.-Forsch./Drug Res. 49 (I), 504 (1999)
3. [3] Duchêne, P., Guidicelli, M. D., Tran, G. et al., Arneim.-Forsch./Drug Res. 49 (II), 608 (1999)